KW-4679, an Antiallergic Drug, Inhibits the Production of Inflammatory Lipids in Human Polymorphonuclear Leukocytes and Guinea Pig Eosinophils

International Archives of Allergy and Immunology

Volumn 110, Issue 1, 1996, Pages 57-63

  Toshihide, Ikemura ^a   Haruhiko, Manabe ^a   Yasuo, Sasaki ^a   Ishii, Hidee ^a   Onuma, Kaori ^a   Miki, Ichiro ^a   Kase, Hiroshi ^a   Sato, Soichiro ^a   Kitamura, Shigeto ^a   Ohmori, Kenji ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Arachidonate release; Guinea pig eosinophils; Human polymorphonuclear leukocytes; KW 4679; Leukotrienes; Platelet activating factor

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANTIALLERGIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; CALCIMYCIN; LEUKOTRIENE; LEUKOTRIENE B4; LIPID; OLOPATADINE; PEPTIDE; PHOSPHOLIPASE A2; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ANIMAL CELL; ARTICLE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHIL; GUINEA PIG; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 15844426336     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237311     Document Type: Article

References (37)

1. Ohshima H, Otaki S. Sato H, Kumazawa T, Obase II, Akio I, Isliii H, Ohmori K, Hiraya-ma N: Synthesis and antiallergic activity of 11 -(aminoalkylidcne)-6. I l-dihydroiiibcnz [b.c] oxepin derivatives. J Med Chem 1992:35: 2074-2084.
2. Ohmori K, Isliii H, Ikemura T, Shirakura R, Ki-tamura S: Inhibitory effect of KW-4679 on antigen-induced late asthmatic response and airway inflammation in guinea pigs. Eur Respir J 1993; 6:318S.
3. Sirois MG. Plante GE. Braquet P. Sirois P: Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways. Br J Pharmacol 1990;101:896-900.
4. llahn IIL, Pumama I, Lang M, Sonnwald U: Effects of platelet activating factor on tracheal mucus secretion, on airways mechanics and on circulating blood cells in live ferrets. Eur J Respir Dis 1986;146:277-284.
5. Tamura H, Agrawal DK, Suliaman FA. Townley RG: Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun 1987;142:638-644.
6. Cuss FM, Dixon CMS, Barnes PJ: EITectsof inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet 1986;2: 189-192.
7. Samuelsson B: Leukotrienes: Mediators of immediate hypersensitivity reaction and inflammation. Science 1983;220:568-575.
8. Ford-Hutchinson AVV. Bray MA. Doig MV. Shipley ME. Smith MJH: Leukotrienc B, a potent chemokinetie and aggregating substance released from polymorphonuclear leukocytes. Nature 1980;286:264-265.
9. Hamberg M. Svcnsson J. Samuelsson B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin cndoperoxidcs. Proc Natl Acad Sci USA 1975; 72:2994-2998.
10. Matsumoto T. Ashida Y: Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane A receptor antagonist (AA2414) in Asians ¿/«»»-allergic dogs. Prostaglandins 1993;46:301-318.
11. Oda M, Satouchi K, Yasunaga K. Saito K: Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. J Immunol 1985;134:1090-1093.
12. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37: 911-917.
13. Rodriguez CG, Montero M, Alvarez J, Garcia-Sancho J, Crespo MS: Dissociation of platelet-activating factor production and arachidonate release by the endomembrane Ca -ATPasc inhibitor thapsigargin: Evidence for the involvement of a Ca -dependent route of priming in the production of lipid mediators by human polymorphonuclear leukocytes. 1 Biol Chem 1993;268:24751-24757.
14. Litt M: Studies in experimental eosinophilia. I. Repeated quantitation of peritoneal eosinophilia in guinea pigs by a method of peritoneal lavage. Blood 1960;16:1318-1329.
15. Gartner I: Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coat-cd silica gel (Percoll). Immunology 1980:40: 133-136.
16. Mollinedo F, Gomez-Cambroncro J, Cano E, Sanchez-Crespo M: Intracellular localization of platelet-activating factor synthesis in human neutrophils. Biochem Biophys Res Commun 1988:154:1232-1239.
17. Miki I, Kishibayashi N, Nonaka H. Ohshima E, Takami II, Obasc II, Ishii A: Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A- antagonist, on human. guinea pig and rat platelets. Jpn J Pharmacol 1992:59:357-364.
18. Yoshimoto T, Yamamoto S, Okuma M, llayaishi O: Solubilization and resolution of thromboxane synthesizing system from micro-somes of bovine blood platelets. J Biol Chem 1977:252:5871 5874.
19. Tomioka H. Yoshida S. Tanaka M. Kumagai A: Inhibition of chemical mediator release from human leukocytes by a new antiasthma drug. I1C20-51I (ketotifen). Monogr Allergy 1979: 14:313-317.
20. Joly F, Bessou G, Bcnvcnistc J, Ninio E: Ketoti-fen inhibits paf-accther biosynthesis and fi-hcx-osaminidase release in mouse mast cells stimulated with antigen. EurJ Pharmacol 1987:144: 133-139.
21. Van den Bosch H: Intracellular phospholipases A. Biochim Biophys Acta 1980:604:191 246.
22. Godfrey RV, Mani RM, Clark MA, Hoftstein ST: Stimulus-specific induction of phospholipid and arachidonic acid metabolism in human neutrophils. J Cell Biol 1987:104: 925-932.
23. 4 synthase activities' Proc Natl Acad Sci USA 1986:83:857-861.
24. Borgeat P, Nadeau M, Salari H, Poubelle P, Fru-tcau de I, aelos B: Leukotriencs: Biosynthesis, metabolism and analysis. Adv Lipid Res 1985: 21:47-77.
25. 4 and PGD) from rat mast cells and guinea-pig lung. Agents Actions 1987:21:125-130.
26. Mueller HW, O'Flaherty IT, Greene DG, Samuel MP, Wykle RL: l-O-alkyl-linkedglycero-phospholipids of human neutrophils: Distribution of araehidonatc and other acyl residues in the ether-linked and diacyl species. J Lipid Res 1984;25:383-388.
27. Chilton FI I, Connell TR: I-Ether-linked phos-phoglycerides. J Biol Client 1988:263:5260 5265.
28. Kudo I, Murakami M, Hara S, Inoue K: Mammalian nonpancreatic phospholipase A,. Bio-cliim Biophys Acta 1993:117:217-231.
29. Mayer RJ. Marshall LA: New insights on mammalian phospholipase A>(s): Comparison of arachidonoyl-selectivc and -nonsclectivc enzymes. FASEB.I 1993:7:339-348.
30. Alonso F. Henson PM. Leslie CC: A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. Biochim Biophys Acta 1986:878:273-280.
31. Rosenthal MD. Vishwanath BS. Franson RC: Effects of aristolochie acid on phospholipase A activity and arachidonate metabolism of human neutrophils. Biochim Biophys Acta 1989: 1001:1-8.
32. 4 biosynthesis in the human neutrophil: Effects of putative inhibitors of phospholipase A. and specific inhibitors of 5-lipoxygcnase. Agents Actions 1991:34:89-92.
33. Grescle P, Ribaldi E, Mezzasoma AM, Quero E, Stasi M, Prosdocimi M, Goracci G, Nenci GG: Gloricromcne inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipids. Biochem Pharmacol 1993:45: 123-130.
34. Kramer RM, Hcssion C, Johansen B. I laves G. McGray P. Cltovv F.P. Tizard R. Pepinskey RB: Structure and properties of a human non-pan-creatic phospholipase A-. J Biol Chcm 1989; 264:5768-5775.
35. Seilhamer JJ. Pruzanski W. Vadas P. Plant S, Miller JA. Kloss J, Johnson LK: Cloning and recombinant expression of phospholipase A, present in rheumatoid arthritic synovial fluid, J Biol Chem 1989:264:5335-5338.
36. Clark JD. Lin LL. Kriz RW. Ramesha CS. Sultz-man LA, Lin AY. Milona N, Knopf JL.: A novel arachidonic acid-selective cytosolic PI.A., contains a Ca -dependent translocation domain with homology to PKC and GAP. Cell 1991:65: 1043-1051.
37. Lin LL. Lin AY. Knopf JL: Cytosolic phospholipase A? is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 1992:89:6147 6151.